Pay in 4 interest-free payments of $5.15 Learn more
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Patients who stop the medication gain back on average two thirds of the weight they had lost
Its designed to activate three receptors involved in weight regulation: GLP-1 (glucagon-like peptide-1) GIP (glucose-dependent insulinotropic polypeptide) Glucagon This triple agonist design is why retatrutide is often described as a triple-hormone weight loss injection
Our take: GLP-1s pills faced investor disappointment over weight loss results that fell short of injectables
Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction
US$ 29.53
US$ 26.89
US$ 28.67
